Form 4 for KURA Kura Oncology, Inc.
Accepted 2026-03-20 00:00:00 ET · period of report 2026-03-18 · accession 0001193125-26-116834 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-20 | 2026-03-18 | KURA | Malley Thomas | Dir | M - OptEx | $3.12 | +10.0K | 10.0K | New | +$31.2K |
| D | 2026-03-20 | 2026-03-18 | KURA | Malley Thomas | Dir | M - OptEx | $0.00 | +10.0K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-18 | M | A | 10,000 | $3.12 | 10,000 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-03-18 | M | A | 10,000 | $0.00 | 0 | D | $3.12 · — to 2026-05-11 | 10,000 Common Stock | (F3) This option is fully vested. |